GXP PHARMAID ApS: Financial statements 2019
CVR: 29615861
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
GXP PHARMAID ApS (CVR 29615861) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 762,547 and a net result of DKK -168,984 compared with DKK 217,265 the year before. That is a decrease of 33.6% compared with the year before. Equity in the 2019 report amounted to DKK 734,965. The solvency ratio was 52.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 762,547
- Profit/Loss
- DKK -168,984
- Equity
- DKK 734,965
- Total Assets
- DKK 1,398,599
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 763 t. | -169 t. | 735 t. | 1 |
| 2018 | - | 1.1 mio. | 217 t. | 904 t. | 1 |
| 2017 | - | 1.4 mio. | 142 t. | 687 t. | 1 |
| 2016 | - | 1.6 mio. | 97 t. | 544 t. | - |
| 2015 | - | 1.9 mio. | -667 t. | 447 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
GXP PHARMAID ApS has published its annual report for 2018. Gross profit came to DKK 1,148,568, and the net result was DKK 217,265.
About GXP PHARMAID ApS
GXP PHARMAID ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The company was previously named Q-VIGILANCE ApS. The management consists of Nusret Asanovski. The company is owned by MAC ANDORBY ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,163,256 and a net result of DKK 122,320 compared with DKK 216,532 the year before. Equity in the 2025 report amounted to DKK 1,218,531.